By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Profectus BioSciences, Inc. 

1450 South Rolling Road

Baltimore  Maryland  21227  U.S.A.
Phone: 443-543-5011 Fax: 443-543-5013



Start Up

Company News
Profectus BioSciences, Inc. Bivalent Vaccine Protects Animals From Infection And Death After Exposure To Chikungunya Or Zika Virus 1/9/2017 9:34:02 AM
Profectus BioSciences, Inc. And Vyriad Form Global Collaboration To Develop Oncolytic Recombinant VSV (rVSV) Vaccines For Cancer Immunotherapy 3/18/2016 6:29:33 AM
Profectus BioSciences, Inc. Initiates Ebola Vaccine Phase 1 Clinical Trial 1/19/2016 6:09:27 AM
Profectus BioSciences, Inc. Receives $4.6 Million DOD Grant To Develop Vaccine For Western, Eastern, And Venezuelan Equine Encephalitis Viruses 12/9/2015 6:44:25 AM
Profectus BioSciences, Inc. Presents Preclinical Data Demonstrating That A Single Dose Of Multi-Component Vaccine Provides Complete Protection Against Zaire And Sudan Species Of Ebola Virus And Marburg Virus 11/17/2015 7:31:28 AM
Profectus BioSciences, Inc.' Ebola Vaccine Shown Effective And Safe In Providing Rapid, Single-Dose Protection Against Current "Makona" Ebola Outbreak Strain In Non-Human Primates 4/9/2015 6:28:51 AM
Profectus BioSciences, Inc. Nabs $9.5 Million Government Grant 10/31/2014 7:21:14 AM
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses 10/22/2014 7:01:47 AM
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies 10/22/2014 6:57:00 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM